Clinical Trial: Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy

Brief Summary: The purpose of this study is to determine whether a medication, Clonidine can reduce the number of days a baby spends in the hospital and the number of days of medical treatment of withdrawal from Neonatal Abstinence Syndrome (NAS) as compared to Morphine Sulfate (used in routine care) .